Episode 395: Pharmacology 101: Monoclonal Antibodies
From The ONS Podcast · · 45 min
This plays from the publisher's own server. We do not host a copy.
Description
"They [monoclonal antibodies] are able to cause tumor cell death by binding to and blocking to necessary growth factor signaling pathways for tumor cell survival. That's going to be dependent on the target of the antibody, but I'll give an example of epidermal growth factor, or EGFR. This is overexpressed in several different kinds of cancers where activation of this growth factor increases the amount of proliferation and migration of cancer cells. So, if we bind to it and block to it, then that would help halt these pathways and stop cancer cell growth," Carissa Ganihong, PharmD, BCOP, oncology and bone marrow transplantation clinical pharmacist at Hackensack University Medical Center in New Jersey, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about monoclonal antibodies.
Music Credit: "Fireflies and Stardust (http://www.incompetech.com/)" by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0
Earn 0.75 contact hours of nursing continuing professional development (NCPD) (including 45 minutes of pharmacotherapeutic content) by listening to the full recording and completing an evaluation at courses.ons.org by December 26, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Learning outcome: Learners will report an increase in knowledge in the history of, the mechanism of action of, and the use of monoclonal antibodies in the treatment of cancer.
Episode Notes
- Complete this evaluation for free NCPD.
- ONS Podcast™ episodes: - Pharmacology 101 series
- Episode 391: Pharmacology 101: Antibody–Drug Conjugates
- Episode 383: Pharmacology 101: Bispecific Antibodies
- Episode 375: Pharmacology 101: VEGF Inhibitors
- Episode 338: High-Volume Subcutaneous Injections: The Oncology Nurse's Role
- Episode 283: Desensitization Strategies to Reintroduce Treatment After an Infusion-Related Reaction
- Episode 275: Bispecific Monoclonal Antibodies in Hematologic Cancers and Solid Tumors
- ONS Voice articles: - An Oncology Nursing Overview of Biosimilars
- Make Subcutaneous Administration More Comfortable for Your Patients
- Oncology Nurses' Role in Translating Biomarker Testing Results
- Reduce Chair Time by as Much as 16 Minutes by Priming IVs With Drug
- Shorter Administration Times Still Require High-Acuity Care
- The Names of Targeted Therapies Give Clues to How They Work
- ONS Voice drug reference sheets: - Datopotamab deruxtecan-dlnk
- Enfortumab vedotin
- Margetuximab-cmkb
- Mirvetuximab soravtansine-gynx
- Nivolumab and hyaluronidase-nvhy
- Nivolumab and relatlimab-rmbw
- Pembrolizumab and berahyaluronidase alfa-pmph
- Retifanlimab-dlwr
- ONS book: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition)
- ONS course: ONS Fundamentals of Chemotherapy and Immunotherapy Administration™
- Clinical Journal of Oncology Nursing articles: - Bolusing IV Administration Sets With Monoclonal Antibodies Reduces Cost and Chair Time: A Randomized Controlled Trial
- Management of Immunotherapy Infusion Reactions
- Nurse-Led Grading of Antineoplastic Infusion-Related Reactions: A Call to Action
- Safety and Adverse Event Management of VEGFR-TKIs in Patients With Metastatic Renal Cell Carcinoma
- Oncology Nursing Forum articles: - Administration of Subcutaneous Monoclonal Antibodies in Patients With Cancer
- Depressive Symptoms and Quality of Life Associated With the Use of Monoclonal Antibodies in Breast Cancer Treatment
- ONS huddle cards: - Bispecifics
- Checkpoint Inhibitors
- Monoclonal Antibodies
- Other ONS resources: - Biomarker Database
- Bispecific Antibodies video
- Patient Education Sheets (https://patienteducationsheets.com/)
- Antibodies article: A…